19-12896949-G-A
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PP5_Very_Strong
The ENST00000222214.10(GCDH):c.892G>A(p.Ala298Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000868 in 1,612,986 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A298V) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000222214.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GCDH | NM_000159.4 | c.892G>A | p.Ala298Thr | missense_variant | 9/12 | ENST00000222214.10 | NP_000150.1 | |
GCDH | NM_013976.5 | c.892G>A | p.Ala298Thr | missense_variant | 9/12 | NP_039663.1 | ||
GCDH | NR_102316.1 | n.1055G>A | non_coding_transcript_exon_variant | 9/12 | ||||
GCDH | NR_102317.1 | n.1273G>A | non_coding_transcript_exon_variant | 8/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GCDH | ENST00000222214.10 | c.892G>A | p.Ala298Thr | missense_variant | 9/12 | 1 | NM_000159.4 | ENSP00000222214.4 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 250426Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135538
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1460778Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 726712
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74354
ClinVar
Submissions by phenotype
Glutaric aciduria, type 1 Pathogenic:4
Likely pathogenic, no assertion criteria provided | clinical testing | Counsyl | Feb 23, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 26, 2017 | Variant summary: The GCDH c.892G>A (p.Ala298Thr) variant located in the Acyl-CoA dehydrogenase/oxidase C-terminal (via InterPro) involves the alteration of a non-conserved nucleotide and 2/4 in silico tools (SNPsandGO not captured here due to low reliability index) predict a benign outcome. This variant was found in 3/120372 control chromosomes at a frequency of 0.0000249, which does not exceed the estimated maximal expected allele frequency of a pathogenic GCDH variant (0.0035355). Multiple publications have cited the variant in affected homozygote and compound heterozygote individuals. Functional analysis found no enzyme activity for a homozygous affected individual and ~50% activity for a unaffected carrier. Therefore, the variant of interest has been classified as "pathogenic." - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 07, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 26, 2023 | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 298 of the GCDH protein (p.Ala298Thr). This variant is present in population databases (rs761765983, gnomAD 0.01%). This missense change has been observed in individual(s) with Glutaric acidemia type I (PMID: 11058907, 15505393, 23104440, 26656312, 27672653). ClinVar contains an entry for this variant (Variation ID: 429706). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GCDH protein function with a negative predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 05, 2022 | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 15505393, 23104440, 26656312, 27672653, 32508882, 32778825, 11058907, 9711871) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at